Medicines Classification




NEW ZEALAND GAZETTE, No. 153 — 18 DECEMBER 2014

Cyclizine; except when specified elsewhere in this notice

Dabrafenib mesilate

Dapagliflozin propanediol

Degarelix

Denosumab

Diclofenac; in preparations for the treatment of solar keratosis; except when specified elsewhere in this notice; except in preparations for external use other than for the treatment of solar keratosis

Dimethyl fumarate

Diphtheria, tetanus and pertussis (acellular, component) vaccine; except when administered in a single dose to a person 18 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

Dolutegravir

Dronedarone

Econazole; except in medicines for vaginal or dermal use

Eculizumab

Elvitegravir

Empagliflozin

Enobosarm

Enzalutamide

Eribulin mesylate

Febuxostat

Ferric carboxymaltose

Fidaxomicin

Fingolimod

Follistatin

Ghrelin

Glycopyrronium

Guaiphenesin; for oral use in medicines containing more than 2% or 200 milligrams per dose form except when specified elsewhere in this notice; except for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply

Hexarelin

Icatibant

Human growth hormone secretagogues

Indacaterol

Influenza vaccine; except when administered to a person 18 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

Ingenol mebutate

Insulin-like growth factors; except where specified elsewhere in this notice

Ipamorelin

Ipilimumab

Isoconazole; except in medicines for vaginal or dermal use

Ivacaftor

Ledipasvir

Linagliptin

Lixisenatide

161



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 153





✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

🏥 Health & Social Welfare
Medicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, Cyclizine, Dabrafenib mesilate, Dapagliflozin propanediol, Degarelix, Denosumab, Diclofenac, Dimethyl fumarate, Diphtheria vaccine, Dolutegravir, Dronedarone, Econazole, Eculizumab, Elvitegravir, Empagliflozin, Enobosarm, Enzalutamide, Eribulin mesylate, Febuxostat, Ferric carboxymaltose, Fidaxomicin, Fingolimod, Follistatin, Ghrelin, Glycopyrronium, Guaiphenesin, Hexarelin, Icatibant, Human growth hormone secretagogues, Indacaterol, Influenza vaccine, Ingenol mebutate, Insulin-like growth factors, Ipamorelin, Ipilimumab, Isoconazole, Ivacaftor, Ledipasvir, Linagliptin, Lixisenatide